Skip to main content

and
  1. No Access

    Article

    Reply to “Screening for high fracture risk”

    T. Merlijn, K.M.A. Swart, J.C. Netelenbos, P.J.M. Elders in Osteoporosis International (2020)

  2. Article

    Open Access

    Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis

    This systematic review and meta-analysis showed a significant reduction of (major) osteoporotic fractures and hip fractures after screening using fracture risk assessment and bone densitometry compared with us...

    T. Merlijn, K.M.A. Swart, H.E. van der Horst, J.C. Netelenbos in Osteoporosis International (2020)

  3. No Access

    Article

    Self-perception of fracture risk: what can it tell us?

    In this study, we report that self-perception of fracture risk captures some aspect of fracture risk not currently measured using conventional fracture prediction tools and is associated with improved medicati...

    A. E. Litwic, J. E. Compston, A. Wyman, E. S. Siris in Osteoporosis International (2017)

  4. Article

    Open Access

    Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

    Several drugs have become available for the treatment of osteoporosis. However, screening and treatment of patients with a high fracture risk is currently not recommended in the Netherlands, because the effect...

    P. J. M. Elders, T. Merlijn, K. M. A. Swart, W. van Hout in BMC Musculoskeletal Disorders (2017)

  5. No Access

    Article

    International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study

    S. Silverman, J. Curtis, K. Saag, J. Flahive, J. Adachi in Osteoporosis International (2015)

  6. No Access

    Article

    Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

    Accurate patient risk perception of adverse health events promotes greater autonomy over, and motivation towards, health-related lifestyles.

    C. L. Gregson, E. M. Dennison, J. E. Compston, S. Adami in Osteoporosis International (2014)

  7. No Access

    Article

    Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

    We evaluated healthcare utilization associated with treating fracture types in >51,000 women aged ≥55 years. Over the course of 1 year, there were five times more non-hip, non-spine fractures than hip or spine...

    G. Ioannidis, J. Flahive, L. Pickard, A. Papaioannou in Osteoporosis International (2013)

  8. No Access

    Article

    Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women

    Among 50,461 postmenopausal women, 1,822 fractures occurred (57% minor non-hip, non-vertebral [NHNV], 26% major NHNV, 10% spine, 7% hip) over 1 year. Spine fractures had the greatest detrimental effect on EQ-5...

    C. Roux, A. Wyman, F. H. Hooven, S. H. Gehlbach, J. D. Adachi in Osteoporosis International (2012)

  9. No Access

    Article

    Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women

    We examined variations in proportions of hip fractures and major fractures among postmenopausal women using the Global Longitudinal Study of Osteoporosis in Women (GLOW). The proportion of major fractures that...

    J. Pfeilschifter, C. Cooper, N. B. Watts, J. Flahive in Osteoporosis International (2012)

  10. Article

    Open Access

    Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

    We analyzed 12-month compliance for all ten oral osteoporosis drugs in the Netherlands by medication possession ratio (MPR ≥ 80%) in 105,506 patients, and persistence in 8,626 starters indicated high MPR (91%)...

    J. C. Netelenbos, P. P. Geusens, G. Ypma, S. J. E. Buijs in Osteoporosis International (2011)

  11. Article

    Open Access

    Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

    We compared self-perception of fracture risk with actual risk among 60,393 postmenopausal women aged ≥55 years, using data from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Most postmenopausa...

    E. S. Siris, S. Gehlbach, J. D. Adachi, S. Boonen in Osteoporosis International (2011)

  12. No Access

    Article

    Spine radiographs to improve the identification of women at high risk for fractures

    In women older than 60 years with clinical risk factors for osteoporosis but without osteoporosis based on bone mineral density (T-score ≥ −2.5), a systematic survey with X-rays of the spine identified previously...

    J. C. Netelenbos, W. F. Lems, P. P. Geusens, H. J. Verhaar in Osteoporosis International (2009)

  13. Article

    Open Access

    The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

    The Global Longitudinal study of Osteoporosis in Women (GLOW) is a prospective cohort study involving 723 physicians and 60,393 women subjects ≥55 years. The data will provide insights into the management of f...

    F. H. Hooven, J. D. Adachi, S. Adami, S. Boonen, J. Compston in Osteoporosis International (2009)

  14. No Access

    Article

    Camurati–Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family

    We report on a 46-year-old mother of Moroccan origin, suffering mainly from painful, swollen legs, and her 26-year-old son who had experienced intense pain in his legs, without fever, for approximately 3 years...

    S. Simsek, K. Janssens, M. L. Kwee, W. Van Hul, J. Veenstra in Osteoporosis International (2005)

  15. No Access

    Article

    Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis

    The effect of pamidronate therapy on bone histology was studied in patients with osteoporosis with at least one vertebral fracture in a randomized, double-masked, placebo-controlled, multi-center trial. Patie...

    N. Bravenboer, S. E. Papapoulos, P. Holzmann, N. A. T. Hamdy in Osteoporosis International (1999)

  16. No Access

    Article

    The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: Results of three years of treatment

    The purpose of this open, prospective, controlled, randomized trial was to study the effect of intermittent, cyclic etidronate on the bone mass of osteoporotic postmenopausal women with or without fractures. E...

    M. L. M. Montessori, W. H. Scheele, J. C. Netelenbos in Osteoporosis International (1997)

  17. No Access

    Article

    The effect of pamidronate on bone histomorphometry in osteoporotic patients

    N. Bravenboer, P. Holzmann, J. C. Netelenbos in Osteoporosis International (1996)

  18. No Access

    Article

    Effects of continuously combined hormone replacement therapy on the biochemical markers of bone turnover

    G. W. de Valk-de Roo, J. C. Netelenbos, E. Peters-Muller in Osteoporosis International (1996)

  19. No Access

    Article

    A test parameter representative for bioavailability of calcium and strontium in rats: Effect of intervention

    R. Barto, A. J. A. M. Sips, M. ten Bolscher, J. C. Netelenbos in Osteoporosis International (1996)

  20. No Access

    Article

    The value of measuring a single biochemical bone marker in the prediction of bone mineral density

    G. W. de Valk-de Roo, J. C. Netelenbos, A. Nicolaas in Osteoporosis International (1996)